During the past decade, Global Cancer Research Institute (GCRI), Inc conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Global Cancer Research Institute (GCRI), Inc" #1 sponsor was "Pfizer" with 2 trials, followed by "Berg, LLC" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Celgene Corporation" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Global Cancer Research Institute (GCRI), Inc" #1 collaborator was "Eisai Limited" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Global Cancer Research Institute (GCRI), Inc" are "Adenocarcinoma" (1 trials), "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Carcinoma" (1 trials) and "Carcinoma, Large Cell" (1 trials). Many other conditions were trialed in "Global Cancer Research Institute (GCRI), Inc" in a lesser frequency.

Most popular intervention types in "Global Cancer Research Institute (GCRI), Inc" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-fluorouracil" (1 trials), "BPM31510 Nanosuspension Injection" (1 trials), "Carboplatin" (1 trials), "E7389" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Global Cancer Research Institute (GCRI), Inc" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Global Cancer Research Institute (GCRI), Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Global Cancer Research Institute (GCRI), Inc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Global Cancer Research Institute (GCRI), Inc, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".